Your search returned 2 results.

Results
	1.	Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirus. [electronic resource] by Corona Gutierrez, Carlos Manual Tinoco, Alberto López Contreras, Mario Navarro, Tania Calzado, Patricia Vargas, Laura Reyes, Lise Posternak, Roberto Rosales, Ricardo Producer: 20020927 In: Human gene therapy vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus. [electronic resource] by Corona Gutierrez, Carlos Manuel Tinoco, Alberto Navarro, Tania Contreras, Mario López Cortes, Roberto Risco Calzado, Patricia Reyes, Lise Posternak, Roberto Morosoli, Gianni Verde, Mauro Lara Rosales, Ricardo Producer: 20041115 In: Human gene therapy vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search